237 related articles for article (PubMed ID: 23223996)
21. Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions.
Gupta A; Singh M; Ibrahim R; Mehrotra R
Acta Cytol; 2007; 51(5):788-94. PubMed ID: 17910350
[TBL] [Abstract][Full Text] [Related]
22. Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions.
Heyden A; Huitfeldt HS; Koppang HS; Thrane PS; Bryne M; Brandtzaeg P
J Oral Pathol Med; 1992 Jan; 21(1):7-11. PubMed ID: 1375644
[TBL] [Abstract][Full Text] [Related]
23. Discrimination of non-melanoma skin lesions from non-tumor human skin tissues in vivo using Raman spectroscopy and multivariate statistics.
Silveira FL; Pacheco MT; Bodanese B; Pasqualucci CA; Zângaro RA; Silveira L
Lasers Surg Med; 2015 Jan; 47(1):6-16. PubMed ID: 25583686
[TBL] [Abstract][Full Text] [Related]
24. Raman spectroscopy in head and neck cancers: toward oncological applications.
Singh SP; Deshmukh A; Chaturvedi P; Krishna CM
J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S126-32. PubMed ID: 22322731
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
[TBL] [Abstract][Full Text] [Related]
26. Near-infrared-excited confocal Raman spectroscopy advances in vivo diagnosis of cervical precancer.
Duraipandian S; Zheng W; Ng J; Low JJ; Ilancheran A; Huang Z
J Biomed Opt; 2013 Jun; 18(6):067007. PubMed ID: 23797897
[TBL] [Abstract][Full Text] [Related]
27. In vivo Raman spectroscopy-assisted early identification of potential second primary/recurrences in oral cancers: An exploratory study.
Malik A; Sahu A; Singh SP; Deshmukh A; Chaturvedi P; Nair D; Nair S; Murali Krishna C
Head Neck; 2017 Nov; 39(11):2216-2223. PubMed ID: 28736959
[TBL] [Abstract][Full Text] [Related]
28. In vivo detection of oral precancer using a fluorescence-based, in-house-fabricated device: a Mahalanobis distance-based classification.
Kumar P; Kanaujia SK; Singh A; Pradhan A
Lasers Med Sci; 2019 Aug; 34(6):1243-1251. PubMed ID: 30659473
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions.
Nagaraju K; Prasad S; Ashok L
Indian J Dent Res; 2010; 21(2):218-23. PubMed ID: 20657091
[TBL] [Abstract][Full Text] [Related]
30. Oral cancer screening: serum Raman spectroscopic approach.
Sahu AK; Dhoot S; Singh A; Sawant SS; Nandakumar N; Talathi-Desai S; Garud M; Pagare S; Srivastava S; Nair S; Chaturvedi P; Murali Krishna C
J Biomed Opt; 2015 Nov; 20(11):115006. PubMed ID: 26580700
[TBL] [Abstract][Full Text] [Related]
31. Oral malignant and premalignant changes in 'Shammah'-users from the Gizan region, Saudi Arabia.
Salem G; Juhl R; Schiødt T
Acta Odontol Scand; 1984 Feb; 42(1):41-5. PubMed ID: 6585122
[TBL] [Abstract][Full Text] [Related]
32. Discrimination of premalignant lesions and cancer tissues from normal gastric tissues using Raman spectroscopy.
Luo S; Chen C; Mao H; Jin S
J Biomed Opt; 2013 Jun; 18(6):067004. PubMed ID: 23736289
[TBL] [Abstract][Full Text] [Related]
33. In vivo Raman spectroscopic characteristics of different sites of the oral mucosa in healthy volunteers.
Carvalho LFCS; Nogueira MS; Bhattacharjee T; Neto LPM; Daun L; Mendes TO; Rajasekaran R; Chagas M; Martin AA; Soares LES
Clin Oral Investig; 2019 Jul; 23(7):3021-3031. PubMed ID: 30402700
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas.
Sawant SS; Vaidya Mm; Chaukar DA; Alam H; Dmello C; Gangadaran P; Kannan S; Kane S; Dange PP; Dey N; Ranganathan K; D'Cruz AK
Oral Dis; 2014 Jul; 20(5):453-65. PubMed ID: 23865921
[TBL] [Abstract][Full Text] [Related]
35. Autofluorescence spectroscopy for in vivo diagnosis of DMBA-induced hamster buccal pouch pre-cancers and cancers.
Wang CY; Tsai T; Chen HC; Chang SC; Chen CT; Chiang CP
J Oral Pathol Med; 2003 Jan; 32(1):18-24. PubMed ID: 12558954
[TBL] [Abstract][Full Text] [Related]
36. Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers.
Jane C; Nerurkar AV; Shirsat NV; Deshpande RB; Amrapurkar AD; Karjodkar FR
J Oral Pathol Med; 2006 Nov; 35(10):595-601. PubMed ID: 17032391
[TBL] [Abstract][Full Text] [Related]
37. Raman spectroscopy can discriminate between normal, dysplastic and cancerous oral mucosa: a tissue-engineering approach.
Mian SA; Yorucu C; Ullah MS; Rehman IU; Colley HE
J Tissue Eng Regen Med; 2017 Nov; 11(11):3253-3262. PubMed ID: 27860386
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of apoptosis in premalignant and malignant epithelia of buccal mucosa].
Jin Y; Deng Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 Aug; 15(3):192-4. PubMed ID: 11479993
[TBL] [Abstract][Full Text] [Related]
39. A pilot study for early detection of oral premalignant diseases using oral cytology and Raman micro-spectroscopy: Assessment of confounding factors.
Behl I; Calado G; Malkin A; Flint S; Galvin S; Healy CM; Pimentel ML; Byrne HJ; Lyng FM
J Biophotonics; 2020 Nov; 13(11):e202000079. PubMed ID: 32686263
[TBL] [Abstract][Full Text] [Related]
40. p53 Overexpression in Oral Mucosa in Relation to Shisha Smoking in Syria and Lebanon.
Zaid K; Azar-Maalouf E; Barakat C; Chantiri M
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1879-1882. PubMed ID: 30049200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
